NEWS
Our Latest News
ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices
ARCHIMED initiates the delisting from Korea Exchange of shares in Jeisys Medical, a leading developer of aesthetic medicine devices, after acquiring Jeisys Medical via change-of-control transactions, including public tenders.
ARCHIMED launches takeover bid for Bomi Italia, international Medtech & Pharma services leader
March
1,
2019
ARCHIMED acquires majority stake in Soest Medical Group
September
6,
2018
ARCHIMED adds two as partners
August
6,
2018
Provepharm Life Solutions forms alliance with new strategic partners, ARCHIMED and Téthys Invest
April
23,
2018
Citieffe announces its first Distal Radius Plate clinical case
December
18,
2017
ARCHIMED raises €315m for second fund
September
20,
2017
368